Management of Folliculitis Decalvans: The EADV Task Force on Hair Diseases Position Statement

    April 2025 in “ Journal of the European Academy of Dermatology and Venereology ”
    Anna Waśkiel‐Burnat, Michela Starace, Matilde Iorizzo, Alexander Katoulis, Zoé Apalla, Leila Asfour, Azael Freites‐Martínez, D. Ioannides, S. Morteza Seyed Jafari, Awatef Kelati, Francesca Pampaloni, Bianca Maria Piraccini, Adriana Rakowska, Andrea Sechi, Anita Takwale, Anastasia Therianou, Lidia Rudnicka
    TLDR Control inflammation and prevent further hair loss in folliculitis decalvans using medications and therapies.
    Folliculitis decalvans is a chronic and relapsing form of scarring alopecia affecting 2.8% of hair loss patients, where the primary goal of treatment is to control inflammation and prevent further hair loss, as regrowth is not expected. The EADV Task Force on Hair Diseases provides recommendations for managing this condition, suggesting oral antibiotics for moderate to severe inflammation and oral glucocorticosteroids for highly active disease. Oral isotretinoin is recommended for mild active disease and refractory cases. Additional treatments include photodynamic therapy, biologics, JAK inhibitors, oral dapsone, hydroxychloroquine, or cyclosporine, with topical or intralesional corticosteroids as adjuncts. Surgical excision, laser therapy, and hair transplantation are options for patients with inactive disease.
    Discuss this study in the Community →

    Research cited in this study

    28 / 28 results

    Related Community Posts Join

    6 / 98 results

      community The Worst Hair Loss Condition You (MAY) have: LPP

      in Research/Science  52 upvotes 1 year ago
      Lichen Planopilaris (LPP) is an autoimmune condition causing permanent hair loss and fibrosis, often misdiagnosed. Treatments include pioglitazone, topical corticosteroids, anti-inflammatory medication, and Jak inhibitors.

      community DHT Harms Scalp Microbiome: DHT Itch is REAL

      in Research/Science  416 upvotes 11 months ago
      Increased Malassezia and Cutibacterium in the scalp microbiome are linked to higher sebum production and inflammation in androgenetic alopecia (AGA). Treatments include ciclopirox shampoo, benzoyl peroxide shampoo, clobetasol propionate, calcipotriol, minoxidil, finasteride, and dutasteride.
      If You Have DUPA, PLEASE READ THIS: Everyone Should Be Scalp Biopsied

      community If You Have DUPA, PLEASE READ THIS: Everyone Should Be Scalp Biopsied

      by nkrata in Research  830 upvotes 1 year ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

      community Hair Loss “Cure” for Inflammation: Topical Roflumilast

      in Research/Science  32 upvotes 1 month ago
      Topical roflumilast is effective for reducing inflammation in various scalp conditions like seborrheic dermatitis, psoriasis, and eczema, but not proven to stop scarring alopecia. Alternatives like apremilast and Vtama are also discussed for their anti-inflammatory benefits.

    Related Research

    2 / 2 results